According to a research report "Surgical Procedures Market By Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Nervous System, Obstetric/Gynecologic), Channel (Physician Offices, Hospitals, ASCs) - US Forecast to 2028" is projected to reach 1,27,748.5 thousand procedures by 2028 from 1,08,275.5 thousand procedures in 2023, at a CAGR of 3.4% during the forecast period.
Browse 24 market data Tables and 27 Figures spread through 86 Pages and in-depth TOC on "Surgical Procedures Market - US Forecasts to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-outpatient-surgical-procedures-market-94756744.html
The growth of the US surgical procedures market is largely driven by the growing prevalence of chronic diseases, the rising geriatric population, technology advancement and increased rate of organ transplantation. On the other hand, complications associated with surgical procedures and risk of surgical errors are likely to refrain the market growth to a certain extent.
The emergence of COVID-19 pandemic resulted in a substantial decline in the procedural volume for most of the surgeries, however, witnessed a considerable increase post-pandemic 2021-2022 due to the backlog emerging from the delay. The US economy is still recovering from the pandemic, however the Russia-Ukraine war and the economic recession are further likely to impact market growth during the forecast years.
The structure of health insurance reimbursements has changed as patients are now more accountable for their healthcare expenses due to increased out-of-pocket (OOP) costs. High-cost sharing has affected treatment decisions, delaying access to care, and has put patients in a difficult financial situation. However, there are certain surgical procedures essential for maintaining health and well-being, such as emergency surgeries, cancer treatment, and procedures to treat chronic conditions, that are expected to witness moderate to low impact of the economic downturn. In addition, the impact may further be influenced by factors such as changes in government policies, advancements in medical technology, and funding for healthcare. Overall, the impact of recession on surgical procedures in the US is complex and multifaceted and may depend on a range of economic, social, and political factors.
In 2022, the dental surgical procedures segment accounted for the largest share of this market.
Based on type, the US surgical procedures market is segmented into orthopedic, gastrointestinal, urologic, dental, cardiovascular, ophthalmic, cosmetic, ENT, obstetric/gynecologic, and other surgical procedures. Sental surgical procedures segment accounted for the largest share in 2022, attributed to the increasing awareness of oral care, rising aging population, growing prevalence of teeth loss, and increasing dental expenditure in the US. According to National Library of Medicine, it is estimated that four out of every five older adults live with at least one chronic disease. Some common chronic conditions have direct impact on the oral health directly affect the teeth and gums, particularly degenerative and disabling ones such as Parkinson’s and Alzheimer’s. Moreover, dental implants have seen growing demand in the above-65 age group. Commonly conducted dental surgeries include:
The physicians offices segment dominated the US surgical procedures market in 2022.
Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. Physician offices held the largest share in 2022, followed by hospitals and ambulatory surgery centers. The large share of this segment can be attributed to factors such as the growth in office-based surgical procedures—in turn, due to the preference for greater autonomy (among physicians), technological advances making office-based surgery feasible for more procedures, and the potential to enhance physician office revenue.
Ambulatory surgery center segment is expected to witness the highest CAGR from 2023 to 2028
The highest CAGR of this segment can be attributed to the potential for cost reduction and the rising demand for better and quicker care among patients. In 2022, specialities that increased their footprint in Ambulatory Surgical Centers (ASCs) included, orthopaedics, cardiology, and higher acuity spine procedures. According to the data from Ambulatory Surgical Center Association, orthopedics was the most common specialty served by ASCs in 2022.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441